
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling
Hongxing Shen, Fengyuan Huang, Xiangmin Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Hongxing Shen, Fengyuan Huang, Xiangmin Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors
Lise T. Jensen, Kathrine E. Attfield, Marc Feldmann, et al.
EBioMedicine (2023) Vol. 97, pp. 104840-104840
Open Access | Times Cited: 32
Lise T. Jensen, Kathrine E. Attfield, Marc Feldmann, et al.
EBioMedicine (2023) Vol. 97, pp. 104840-104840
Open Access | Times Cited: 32
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial
Georgina V. Long, Matteo S. Carlino, George Au‐Yeung, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2540-2548
Open Access | Times Cited: 15
Georgina V. Long, Matteo S. Carlino, George Au‐Yeung, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2540-2548
Open Access | Times Cited: 15
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade
Julia Holzgruber, Christina Martins, Zsófi Kulcsár, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Julia Holzgruber, Christina Martins, Zsófi Kulcsár, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
Hannah M. Neuendorf, Jacinta L. Simmons, Glen M. Boyle
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Hannah M. Neuendorf, Jacinta L. Simmons, Glen M. Boyle
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 14
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 14
The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
Chun Wai Wong, Yang Huang, Adam Hurlstone
Essays in Biochemistry (2023) Vol. 67, Iss. 6, pp. 991-1002
Open Access | Times Cited: 11
Chun Wai Wong, Yang Huang, Adam Hurlstone
Essays in Biochemistry (2023) Vol. 67, Iss. 6, pp. 991-1002
Open Access | Times Cited: 11
HIF1α-regulated glycolysis promotes activation-induced cell death and IFN-γ induction in hypoxic T cells
Hongxing Shen, Oluwagbemiga A. Ojo, Haitao Ding, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Hongxing Shen, Oluwagbemiga A. Ojo, Haitao Ding, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases—Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway
Chiara Massa, Yuan Wang, Nico Marr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6736-6736
Open Access | Times Cited: 10
Chiara Massa, Yuan Wang, Nico Marr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6736-6736
Open Access | Times Cited: 10
Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors
Piotr Wawrzyniak, Mariusz L. Hartman
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Piotr Wawrzyniak, Mariusz L. Hartman
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Mechanistic insights into proteasome inhibitor MG132 induced apoptosis in melanoma A375 cells
Meng Xu, Ziqing Zhang, Xinyi He, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Meng Xu, Ziqing Zhang, Xinyi He, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer
Oluwagbemiga A. Ojo, Hongxing Shen, Jennifer Ingram, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Oluwagbemiga A. Ojo, Hongxing Shen, Jennifer Ingram, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates
Attila A. Seyhan, Claudio Carini
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 41-41
Open Access | Times Cited: 10
Attila A. Seyhan, Claudio Carini
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 41-41
Open Access | Times Cited: 10
drexml: A command line tool and Python package for drug repurposing
Marina Esteban‐Medina, Víctor Manuel de la Oliva Roque, Sara Herráiz-Gil, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1129-1143
Open Access | Times Cited: 1
Marina Esteban‐Medina, Víctor Manuel de la Oliva Roque, Sara Herráiz-Gil, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1129-1143
Open Access | Times Cited: 1
Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival
L. Black, Jody Fromm Longo, Joshua C. Anderson, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 9, pp. 1298-1318
Open Access | Times Cited: 3
L. Black, Jody Fromm Longo, Joshua C. Anderson, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 9, pp. 1298-1318
Open Access | Times Cited: 3
Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities
Amber B. Jones, Taylor L. Schanel, Mikayla R. Rigsby, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2171-2171
Open Access | Times Cited: 2
Amber B. Jones, Taylor L. Schanel, Mikayla R. Rigsby, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2171-2171
Open Access | Times Cited: 2
HIF1α-glycolysis engages activation-induced cell death to drive IFN-γ induction in hypoxic T cells
Lewis Z. Shi, Hongxing Shen, Logan J. Mullen, et al.
Research Square (Research Square) (2024)
Open Access
Lewis Z. Shi, Hongxing Shen, Logan J. Mullen, et al.
Research Square (Research Square) (2024)
Open Access
Gfi1 controls the formation of exhausted effector-like CD8 T cells during chronic infection and cancer
Oluwagbemiga A. Ojo, Hongxing Shen, Jennifer Ingram, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Oluwagbemiga A. Ojo, Hongxing Shen, Jennifer Ingram, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
HiJAKing Immunotherapy-Resistant Melanoma for a Cure
Lewis Z. Shi, Hongxing Shen, Oluwagbemiga A. Ojo, et al.
The Oncologist (2023) Vol. 28, Iss. 3, pp. 196-198
Open Access
Lewis Z. Shi, Hongxing Shen, Oluwagbemiga A. Ojo, et al.
The Oncologist (2023) Vol. 28, Iss. 3, pp. 196-198
Open Access